Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what representations (a) he is and (b) officials of his Department are making to counterparts in Lithuania on allowing British travellers arriving in Lithuania who have received the AstraZeneca/Oxford covid-19 vaccines sourced from the Serum Institute of India to follow regulations in Lithuania in-line with people who are fully vaccinated with other approved covid-19 vaccines.

The Government is in close touch with partners across Europe, including Lithuania, on the issue of EMA approval of the 5 million doses of AstraZeneca that were manufactured under license by the Serum Institute of India for use in the UK. Officials are currently in discussions with Lithuanian counterparts to confirm that Lithuanian authorities will regard those vaccinated in the UK with these doses as vaccinated for the purposes of entry to Lithuania. The Government stands ready to share further details of the MHRA's approval of this particular batch should it be required.